HomeNewsBusinessCompaniesEmployees at Bajaj Auto's Aurangabad plant test positive for COVID-19

Employees at Bajaj Auto's Aurangabad plant test positive for COVID-19

Bajaj makes RE brand of three-wheelers, Platina, CT100 and the Qute at the Aurangabad plant.

June 26, 2020 / 20:24 IST
Story continues below Advertisement

Bajaj Auto on June 26 said some of its employees at the Aurangabad plant have tested positive for Covid-19.

"We have more than 8100 employees and contractors employed in our Waluj plant. Our current incidence of 140 cases of Covid is less than 2 percent of our strength. Two of our infected employees with underlying conditions of hyper tension and diabetes have unfortunately succumbed to the infection," said Ravi Kyran Ramasamy, CHRO, Bajaj Auto Ltd.

Story continues below Advertisement

This is first time Bajaj Auto has reported Covid-19 positive case since easing of the lockdown restrictions and partial resumption of production activity. Bajaj makes RE brand of three-wheelers, Platina, CT100 and the Qute at the Aurangabad plant.

“From April 24 till June 6, 2020, we had no Covid 19 incidence at our Waluj (Aurangabad) plant. Our first case was reported on June 6. We have immediately taken all necessary measures for testing, contact tracing, self-isolation and complete sanitation as per protocol. All incidences were reported to the appropriate authorities," it said in a statement.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show